Higher Survival is tied to Care at High-Volume Radiation Treatment Centers
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Aug. 16, 2023 -- Among men with very high-risk prostate cancer, higher radiation facility case volume is independently associated with longer overall survival, according to a study published online Aug. 8 in JAMA Network Open.
Nikhil Sebastian, M.D., from Emory University in Atlanta, and colleagues examined differences in outcomes between patients with very high-risk prostate cancer treated at radiation facilities with high versus low patient volume. The analysis included 25,219 men identified from the National Cancer Database.
The researchers found that 25.5 percent of men were treated at facilities with high average cumulative volume. During a median of 57.4 months of follow-up, median overall survival was 123.4 months for men treated at high-volume centers versus 109.0 months for those treated at low-volume centers. Further, treatment at a high-volume center was associated with a lower risk for death (hazard ratio, 0.89). Results remained significant after inverse probability score weight-based adjustment.
"These findings suggest that the expertise and resources that accompany high-volume treatment facilities are associated with improved outcomes for men with very high-risk prostate cancer, but further investigation is needed to identify the specific causes for this association," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
New Tool IDs Sexual Struggles in Female Partners of Prostate Cancer Patients
FRIDAY, May 24, 2024 -- The Sexual Concerns In Partners of Patients with Prostate cancer tool is a valid measure of sexual health in female partners of patients with prostate...
Plant-Based Diet May Aid Prostate Cancer Outcomes
FRIDAY, May 3, 2024 -- Consuming a primarily plant-based diet may be associated with better cancer-specific health outcomes among men with prostate cancer, according to a study...
Neoadjuvant Chemohormonal Therapy Aids Locally Advanced Prostate Cancer
THURSDAY, May 2, 2024 -- For patients with locally advanced prostate cancer, neoadjuvant chemohormonal therapy (NCHT) is beneficial for biochemical progression-free survival...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.